Dereje A. Negatu, Ph.D.
@Zdereje
Followers
125
Following
626
Media
15
Statuses
280
Interested in TB and NTM, AMR, Biostatistics
United States
Joined August 2012
ኢትዮጵያ በአለም ቀዳሚ የጥናት እና ምርምር የሚወገድባት ሀገር እንደሆነች Chemical and Engenering News ዘግቧል። Ethio-BioMed HUB ምንጩን ባጣራው መሰረት 75% የሚሆኑት ከቴክኖሎጂ እና ኢንጂነሪንግ ዘርፍ እንደሚመነጩ አረጋግጧል። ሙሉ ከዚህ ያገኙታል!.
0
0
0
Merry Christmas for those celebrating tomorrow!.
0
0
1
RT @abebawfekadu: We must make biomedical research affordable and demystify medical product development. Is the only way Africa can make th….
www.linkedin.com
Africa and its partners appear to be aligned on the agenda of pharmaceutical manufacturing. Loans are being approved, consultants are engaged, and international organizations are supportive.
0
2
0
Our recent work that demonstrates the recently approved durlobactam enhances the potency of the existing standard-of-care beta-lactams against Mycobacterium abscessus.
journals.asm.org
Mycobacterium abscessus pulmonary disease (Mab-PD) is treated for many months to years with multiple antibiotics until sputum cultures remain negative for 12 months. Yet cure rates are poor, around...
0
4
11
RT @AnaMarciaSG: Multidrug tolerance conferred by loss-of-function mutations in anti-sigma factor RshA of Mycobacterium abscessus https://….
journals.asm.org
Mycobacterium abscessus (Mab) accounts for most pulmonary infections caused by fast-growing non-tuberculous mycobacteria (NTM). There is currently no reliable cure for Mab pulmonary disease (Mab-PD)...
0
5
0
RT @StrongLabNJH: New research paper: Evaluation of the GenoType #NTM-DR line probe assay for #nontuberculous #mycobacteria using whole gen….
0
1
0
ስለ ግለሰብ ተኮር የስኳር ህክምና ላይ የተደረገ ውይይት።
Honored to host a discussion on Precision Medicine in Diabetes by Dr Adem Yesuf. We thank our presenter and guests (Dr Melaku Taye @MelakuTayeMD, Dr Demisse Tadesse) for their insightful discussion. @AlemayehuGK
0
0
0
We hosted Dr. Solomon Tadesse Zeleke, who discovered and holds a patent with his team on novel anti-cancer CDK4/CDK6 inhibitors, currently in phase I and II clinical trials.
0
0
0
Thank you Dr Abinet @Nephronette for sharing with us your impactful paper published in #JAMA on the long-term impact of COVID-19 on acute kidney injury (AKI). Thank you Dr. Workagegnehu @drworke for joining us.
0
0
2
RT @ABsteward: The Dual β-lactam approach has been successfully applied to overcome target redundancy in NTM !.Surprisingly, this approach….
journals.asm.org
β-lactams are the preferred agents for the treatment of a wide range of bacterial infections and are among the oldest antibiotics in medical practice. They have excellent safety profiles upon...
0
14
0
I am thrilled to announce the publication of our latest short paper titled "A pairwise approach to revitalize Beta-lactams for the Rx of MTB" #cefuroxime, #amoxacilin, #tebipenem, #sulopenem
journals.asm.org
β-lactams are the preferred agents for the treatment of a wide range of bacterial infections and are among the oldest antibiotics in medical practice. They have excellent safety profiles upon...
0
0
2
I am privileged to host a discussion on the work of Prof. Markos @MarkosTesfaye1, which was recently published in Nature Molecular Psychiatry. Thank you Prof for your time and dedication. I also thank Dr Dawit Assefa, Dr Bisrat Woldemichael, and Dr Tizibt Ashine.
1
0
3
Honored to host a discussion with @AshenafiBulle @BiniyamTeferaD @TessAdmasu on combination drug therapy for cancer Rx. @hiwottibebu2 @YetenaW @fitse_t @AlemayehuGK.
Deeply grateful for the engaging discussion with Dr. @AshenafiBulle Bulle on his innovative work on combination therapy for pancreatic cancer. Thanks also go to Dr @BiniyamTeferaD for his clinical insights and to Dr @TessAdmasu for highlighting its aging-related benefits.
0
1
3
RT @ethiobiomedhub: As part of our goal to advocate for Biomedical science in Ethiopia, we have highlighted the most successful and impactf….
www.youtube.com
0
5
0
Comprehnsive review on therapeutic developments for TB and NTM lung diseases
0
0
2
I am thrilled to announce the launch of a YouTube channel dedicated to biomedical scientists. We aim to share our experiences and scientific achievements with Ethiopian audiences in an accessible manner. #subscribe, #share
www.youtube.com
This platform is dedicated to biomedical science to foster collaboration and networking
0
0
4
RT @JIDJournal: Oral β-lactam pairs for the treatment of Mycobacterium avium complex pulmonary disease. ✅ Just Accepted.🔓 Open Access.https….
academic.oup.com
Oral β-lactam pairs combining tebipenem, sulopenem, or amoxicillin with cefuroxime achieve strong bactericidal activity at recommended doses against pulmon
0
3
0